University of Iowa
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Iowa sits in the top decile of US sponsors by registered trial count (#143 of 15,742 sponsors by registered trial count).
University of Iowa: 228 sponsored US clinical trials, 28 recruiting.
University of Iowa sponsors 228 registered US clinical trials on ClinicalTrials.gov, 28 of them currently recruiting, and 156 completed. 23 of these trials are in Phase 3-4 (later-stage) and 49 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 6 trials.
Top-decile sponsor footprint
University of Iowa ranks in the top decile of sponsors by registered trial count (#143 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
156 of 184 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
228 total, page 1 of 5
Genetic Risk Factor for Heat Stroke
NCT06847256
Probing the Role of Mitochondrial Oxidative Stress in Impaired Vascular Function Among Young Adults With Early Life Adversity
NCT07244809
Robotic-Assisted Versus Manual Electrode Array Insertion
NCT06951594
Effect of Custom Dynamic Orthoses on Forefoot Loading
NCT06710119
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial
NCT06405607
E-Tailored Pain Management Support for Dementia Family Caregivers: Feasibility of the PACE-app
NCT07032350
PERceptions of Diltiazem Versus ADEnosine for Treatment of Supraventricular Tachycardia in the Emergency Department
NCT07086560
Aquagenic Wrinkling Prediction
NCT06831110
Outcomes of Limited Postoperative Restrictions Following Sling Placement: A Randomized Controlled Trial
NCT06840093
IV vs Epidural Opioids + Epidural Local Anesthetic for Laparotomy Analgesia
NCT06559969
Cognitive Control to Boost Physical Activity Adherence
NCT06338774
The Effects of Heel Distraction Height on Foot Loading With Carbon Fiber Custom Dynamic Orthoses
NCT06127316
Role of Inflammation in Vascular Phenotype Associated With E-cigarette Use
NCT06489249
Comparing Approaches to Assess Nitric Oxide-dependent Cutaneous Vasodilation
NCT06499844
177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry
NCT06395402
Reliability of Force Measurement Within the Carbon Fiber Orthosis Proximal Cuff
NCT06127264
Acceptance and Commitment Therapy for Patients Undergoing Coronary Artery Bypass Graft Surgery
NCT06207318
Regional Nerve Blocks to Improve Analgesia and Recovery in Older Adults Undergoing Spinal Fusion
NCT05461092
Omega-3 Fatty Acid Lipidomics in Diabetes Peripheral Neuropathy
NCT05169060
Language Outcomes, Mechanisms, and Trajectories in Adults With and Without Developmental Language Disorder
NCT06898671
Single Arm Study of Neoadjuvant Dostarlimab in Stage II and III Deficient Mismatch Repair Colon Cancers
NCT05239546
COVID-19 Coagulopathy Extension Study
NCT05334615
CT-Based Changes in Bone and Marrow Among Patients on Oral Steroids
NCT04518722
MMP-9 Inhibition for Recalcitrant Wet AMD
NCT04504123
Longitudinal Assessment of Brain Structure and Function in Juvenile-onset Huntington's Disease
NCT05707663
Carbon Dioxide (CO2) Chemosensitivity and SUDEP
NCT04134754
The Effects of AFO Heel Height and Stiffness on Gait
NCT04800484
Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2
NCT01193088
Pharmacist Intervention to Improve Smoking Cessation
NCT06943287
Pharmacokinetics of Transdermal Metronidazole
NCT05929794
Effect of VLCD on the Reduction of Liver Steatosis and Fibrosis in Subjects With Obesity and NAFLD
NCT04861571
Birth to Three - Cavity Free
NCT05756413
Activity and Cancer Survivorship Exercise Pilot
NCT07283029
Neuroendocrine Tumors - Patient Reported Outcomes
NCT05064150
Critical Illness Myopathy and Trajectory of Recovery in AKI Requiring CRRT
NCT05287204
Telerehabilitation After Shoulder Arthroplasty
NCT05499728
Target Engagement of Terazosin in Healthy Adults
NCT04551040
Cerebellar TDCS for SRPCS Treatment
NCT04760899
Casting vs Bracing for Idiopathic Early-Onset Scoliosis
NCT04500041
Cystoealstometer (Bladder Monitor Device)-Home Use
NCT05232253
Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot)
NCT04634227
Effects of Transitional Circulation in ELBW Infants
NCT02016599
Dimensional Changes: Randomized Clinical Trial
NCT05684068
Effect of Terazosin on ATP Levels in People With Amyotrophic Lateral Sclerosis
NCT07224269
Evaluation of a Habit-based Work-up to Support Medication Adherence
NCT06230978
A Pharmacist Intervention to Improve Mother and Child Health
NCT06073054
Wearable Bioimpedance Analyzer for Tracking Body Composition Changes
NCT05986617
Comparative Effect of Carbon Fiber Orthosis Cuff Design on Preference, Comfort, and Mechanics
NCT05456295
Pregabalin for Central Sensitization in TKA
NCT05460871
Reducing ESKAPE Transmission in the Operating Room
NCT06274918
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 22 |
| Phase 2 | 27 |
| Phase 3 | 4 |
| Phase 4 | 19 |
Therapeutic Areas
What is open in the University of Iowa pipeline
28 recruiting of 228 indexed (12% open); 156 completed (68%).
Phase mix: 23 late (III/IV) vs 49 early (I/II) (early-phase heavy).
Top condition: Healthy (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Iowa: open-pipeline peers nationwide
Peers matched on 228 registered trials and 12% open enrollment, not the therapeutic-area sidebar.
University of Iowa sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 228 trials (± recruiting share)
- Georgetown University · 227 trials · 15% recruiting
- University Hospitals Cleveland Medical Center · 230 trials · 18% recruiting
- Brown University · 231 trials · 15% recruiting
- Henry Ford Health System · 234 trials · 18% recruiting
Sponsors near 12% open enrollment (± trial volume)
- Daiichi Sankyo · 12% recruiting · 236 trials
- Augusta University · 12% recruiting · 106 trials
- National Institute of Mental Health (NIMH) · 12% recruiting · 343 trials
- Friends Research Institute · 12% recruiting · 41 trials
Related
What to do with this University of Iowa page
228 registered trials is a research-attention snapshot, not an endorsement of University of Iowa or any single study.
- 28 of University of Iowa's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition University of Iowa studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Iowa pipeline card: 228 registered trials from official public datasets.Report a data error.